Clinical trial
Chloroquine as Adjuvant to the Treatment of Glioblastoma Multiforme, A Randomized Trial
NCT00224978 is registered in ClinicalTrials.gov with National Institute of Neurology and Neurosurgery, Mexico as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Chloroquine as Adjuvant to the Treatment of Glioblastoma Multiforme, A Randomized Trial
- Lead sponsor
- National Institute of Neurology and Neurosurgery, Mexico
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- August 31, 2005
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
glioblastoma multiforme